На этой странице перечислены больницы направления «Гинекология» (включая Cervical Cautery (Cervical Erosion Treatment)) в Дубай, ОАЭ, включая Burjeel Hospital for Advanced Surgery Dubai, Kings College Hospital Dubai, Aster Hospital Dubai.
Спросите нас о «Cervical Cautery (Cervical Erosion Treatment)» в Дубай, ОАЭ
Оставьте свои данные — наша команда координации свяжется с вами и расскажет о следующих шагах.
Сравните 3 аккредитованных больниц (Гинекология) в Дубай, ОАЭ
Рекомендуем🇦🇪 Burjeel Hospital for Advanced Surgery Dubai
Больница занимает 1-е место в этом списке по указанному рейтингу (4.5/5, 1 отзывов).
🇦🇪 Kings College Hospital Dubai
Больница занимает 2-е место в этом списке по указанному рейтингу (4.5/5, 1 отзывов).
🇦🇪 Aster Hospital Dubai
Больница занимает 3-е место в этом списке по указанному рейтингу (4.5/5, 1 отзывов).
Как мы выбираем эти больницы
Больница появляется на этой странице, если направление «Гинекология» указано среди её специализаций и она находится в Дубай, ОАЭ. Сортировка — по указанному рейтингу (по убыванию), без редакционного рейтинга «лучших».
Как выбрать лучшую больницу для «cervical cautery (cervical erosion treatment)» в Дубай, ОАЭ?
Выбор подходящей больницы для «cervical cautery (cervical erosion treatment)» — важное решение в вашем пути лечения. Вот на что стоит обратить внимание:
Международная аккредитация
Ищите больницу с международной аккредитацией, например JCI или NABH — см. отметки аккредитации у каждой больницы ниже.
Специализация
Убедитесь, что в больнице есть отделение, специализирующееся на «Гинекология», а не только общая помощь.
Мощность и опыт
Количество коек и год основания, указанные ниже, отражают масштаб и операционный опыт больницы.
Прозрачность стоимости
Запросите детализированную смету перед поездкой — используйте наш калькулятор стоимости для первичной оценки.
Что нужно знать о процедуре «Cervical Cautery (Cervical Erosion Treatment)»
Cervical cautery, also known as cervical erosion treatment or cervical ectropion ablation, is a minimally invasive gynaecological procedure that uses thermal, chemical, or cryogenic energy to eliminate abnormal or inflamed cervical tissue, restoring the transformation zone to its healthy state. Clinical success rates for symptom resolution exceed 85–95% depending on the technique employed and the severity of the ectropion. International patients choose India and the UAE through GAF Healthcare for access to JCI- and NABH/DHA-accredited centres, fellowship-trained gynaecologists, and treatment costs that represent significant savings over Western healthcare systems — all supported by end-to-end concierge logistics. Hospital Stay: 0–1 days (day-case or overnight observation; most patients are discharged within 4–6 hours of the procedure) • Total Stay in Country (Fit-to-Fly): 1–2 weeks (standard discharge advice is to avoid strenuous activity and long-haul flight-associated dehydration for a minimum of 7–10 days post-procedure; your treating gynaecologist will issue a fit-to-fly certificate based on individual recovery) • Success Rate: 85–95% (symptom resolution; re-treatment rate approximately 5–10% for large or deeply glandular ectropions)
Clinical Overview
Cervical ectropion (historically and colloquially termed 'cervical erosion') occurs when the columnar epithelium that normally lines the endocervical canal migrates outward onto the ectocervix, forming a visible, often inflamed red zone around the external os. This metaplastic transformation zone is physiologically normal in adolescents, pregnant women, and those using combined oral contraceptives due to oestrogen-driven eversion of the cervix; however, when it becomes symptomatic — causing persistent mucopurulent discharge, post-coital bleeding (PCB), pelvic discomfort, or recurrent cervicitis — clinical intervention is indicated. The condition is not a true erosion or malignancy, but its columnar epithelium is more vulnerable to infection by sexually transmitted pathogens such as Chlamydia trachomatis and Neisseria gonorrhoeae, and the transformation zone itself is the site where high-risk HPV integration and cervical intraepithelial neoplasia (CIN) most frequently develop. The physiological impact of a symptomatic ectropion extends beyond localised irritation. Chronic cervicitis driven by secondary bacterial colonisation of the ectopic columnar epithelium can ascend to cause endometritis and, in severe cases, contribute to subfertility through altered cervical mucus quality and impaired sperm transport. Post-coital and intermenstrual bleeding, while rarely indicative of malignancy, causes significant psychological distress and must always prompt colposcopic assessment and directed biopsy to exclude CIN, squamous cell carcinoma, or adenocarcinoma in situ before any ablative treatment is undertaken. The current standard of care, as endorsed by the Royal College of Obstetricians and Gynaecologists (RCOG) and reflected in protocols at leading Indian and UAE centres, mandates an up-to-date cervical smear (liquid-based cytology, LBC), high-risk HPV co-testing, and colposcopy with biopsy of any acetowhite, mosaic, or punctate lesion before offering ablative or excisional therapy. Once malignancy and high-grade CIN are excluded, the clinician selects the most appropriate energy modality — cold coagulation, large-loop excision of the transformation zone (LLETZ/LEEP), cryotherapy, silver nitrate chemical cautery, or diathermy (electrocautery/radiofrequency ablation) — based on ectropion size, symptom severity, patient parity, and the desire to preserve fertility.
Who is a Candidate?
• IDEAL CANDIDATES: • Women with symptomatic cervical ectropion confirmed on speculum examination and colposcopy, presenting with one or more of: profuse mucopurulent or clear discharge refractory to antibiotic therapy, recurrent post-coital bleeding (after malignancy excluded), chronic pelvic discomfort attributed to cervical inflammation, or repeated cervicitis episodes • Women with an ectropion measuring >1 cm in diameter that has not responded to conservative management or treatment of underlying infection • Women who have completed their family or who have been counselled on fertility implications of the chosen technique • Women with a negative or low-grade (CIN 1) cervical biopsy result who wish to avoid ongoing surveillance anxiety • REQUIRED PRE-PROCEDURE DIAGNOSTICS: • Liquid-based cytology (LBC) cervical smear — must be within 12 months (or performed at initial consultation) • High-risk HPV DNA testing (HPV 16, 18, and other high-risk genotypes) — co-testing preferred • Colposcopy with acetic acid and Lugol's iodine application, including directed punch biopsy of any abnormal-appearing areas • Endocervical swabs: Chlamydia trachomatis (NAAT), Neisseria gonorrhoeae (NAAT), bacterial vaginosis screen, and candida • Transvaginal ultrasound (TVUS) to exclude concurrent uterine or adnexal pathology • Full blood count (FBC), coagulation profile (PT/APTT/INR) if electrosurgical technique planned • Pregnancy test (urine or serum beta-hCG) — pregnancy is an absolute contraindication to ablative cautery • STI screen including HIV, Hepatitis B surface antigen where clinically indicated • RELATIVE CONTRAINDICATIONS: • Active cervicitis or unresolved pelvic inflammatory disease (PID) — treat infection first, defer procedure by minimum 6–8 weeks • Current pregnancy (all ablative methods are contraindicated; ectropion in pregnancy is managed conservatively) • Known or suspected high-grade CIN (CIN 2/3), AIS, or invasive cervical cancer — requires excisional treatment (LLETZ/LEEP/cone biopsy) or oncological referral, not simple ablation • Unresolved coagulation disorder not optimised pre-operatively • Immunosuppression (e.g., post-transplant, active autoimmune therapy) — requires specialist risk–benefit discussion • Patient preference against the procedure after full informed consent discussion
Treatment Options & Approaches
TREATMENT APPROACHES FOR CERVICAL ECTROPION: 1. SILVER NITRATE CHEMICAL CAUTERY The most conservative office-based technique. A silver nitrate applicator stick (75% concentration) is applied directly to the ectropion under direct vision without local anaesthesia. The coagulative chemical precipitates surface proteins, causing superficial tissue necrosis and stimulating squamous metaplasia. Best reserved for small (<1 cm), mildly symptomatic ectropions. Discomfort is minimal; a brown-black eschar forms and separates over 7–14 days. Single-session efficacy is approximately 60–70%; repeat applications may be needed. Does not generate a histological specimen. 2. CRYOTHERAPY (CRYOCAUTERY) A cryoprobe cooled by liquid nitrogen or nitrous oxide (−80°C to −196°C) is applied to the ectropion for two freeze–thaw–freeze cycles of 3 minutes each. Ice-crystal formation destroys the columnar epithelium to a depth of 3–5 mm. Effective for ectropions up to 3 cm with no endocervical extension. A significant watery vaginal discharge lasting 3–4 weeks post-procedure is expected as the necrotic tissue sloughs. Efficacy: 80–90% for symptom resolution. No specimen generated; therefore HPV/CIN status must be confirmed negative before use. Still widely used in lower-resource settings and NABH-accredited district hospitals in India. 3. COLD COAGULATION (SEMM COAGULATOR) Despite its name, 'cold coagulation' uses a Teflon probe heated to 100–120°C applied for 20–30 seconds per site. The technique is office-based, requires no general anaesthesia, produces less vapour/smoke than diathermy, and achieves tissue destruction to 4–6 mm depth. Multiple overlapping applications cover the entire transformation zone. Clinically preferred over cryotherapy in the UK (RCOG-endorsed) for outpatient ablation due to superior depth control and reduced discharge duration. Success rate 85–95%. 4. DIATHERMY / RADIOFREQUENCY ELECTROCAUTERY Monopolar or bipolar radiofrequency (RF) energy (typically 3.8–4 MHz devices such as Ellman Surgitron or Medtronic Valleylab) is delivered via a ball or loop electrode. Thermal coagulation destroys tissue to a controlled depth of 3–8 mm. RF diathermy is performed under local anaesthetic (intracervical block with 1% lignocaine ± vasopressin). It is rapid, precise, and effective for larger or irregularly shaped ectropions. Produces smoke plume requiring evacuation. Success rates 88–95%. 5. LARGE LOOP EXCISION OF THE TRANSFORMATION ZONE (LLETZ / LEEP) The gold-standard excisional technique when histological confirmation of the transformation zone is required, or when colposcopic findings are borderline/equivocal. A thin wire loop (15–25 mm) energised with blended cutting/coagulation current excises the entire transformation zone as a single specimen, submitted for histopathological analysis. Performed under local anaesthetic (intracervical block). LLETZ simultaneously treats the ectropion and provides definitive tissue diagnosis. Depth of excision 7–10 mm for type 1–2 transformation zones. Mild bleeding risk (haemostasis achieved with ball diathermy); very rare risk (<1%) of cervical stenosis. Preferred technique in JCI/NABH centres for women with any colposcopic uncertainty. 6. LASER VAPORISATION (CO₂ LASER) CO₂ laser (10,600 nm wavelength) vaporises the transformation zone with submillimetre precision under colposcopic guidance. Permits variable depth (2–7 mm) with minimal lateral thermal damage (~0.1 mm). Extremely low bleeding risk; superior healing time. Available at premium JCI-accredited tertiary centres in India (AIIMS, Tata Memorial, Apollo, Fortis) and in the UAE (Cleveland Clinic Abu Dhabi, Mediclinic City Hospital Dubai). Success rates 90–97%. Higher equipment cost makes it less widely available but offers the best outcomes for large or complex ectropions. TECHNOLOGY COMPARISON SUMMARY: • Office-based, no anaesthesia: Silver nitrate, cryotherapy • Office-based, local anaesthesia: Cold coagulation, RF diathermy, LLETZ • Theatre-based, local or general anaesthesia: LLETZ (large lesions), CO₂ laser • Provides histological specimen: LLETZ only (among ablative options) • Highest precision/lowest collateral damage: CO₂ laser > RF diathermy > cold coagulation
Восстановление
PRE-PROCEDURE PHASE (2–4 weeks before travel or at receiving centre): • Step 1 — Remote Consultation: GAF Healthcare co-ordinates a telemedicine session with the receiving gynaecologist. The patient uploads recent smear results, HPV test, and any previous colposcopy reports. Medical history, menstrual cycle, contraception, and STI history are reviewed. • Step 2 — Pre-procedure Diagnostics (at destination if not done locally): Liquid-based cytology, HPV DNA testing, colposcopy, directed biopsy (results within 48–72 hours at accredited labs), TVUS, swabs, blood tests, pregnancy test. The procedure is not booked until biopsy results confirm absence of high-grade CIN or malignancy. • Step 3 — Scheduling: Procedure is ideally scheduled in the first half of the menstrual cycle (days 5–14) to avoid the luteal phase and reduce bleeding risk. Patient is advised to avoid intercourse and intravaginal products for 48 hours prior. PROCEDURE DAY: • Step 4 — Admission: Day-case admission. No general anaesthesia required for the majority of techniques (silver nitrate, cryotherapy, cold coagulation, RF diathermy, LLETZ under local block). The patient changes into a gown; a cannula is sited if IV sedation is offered for anxious patients. • Step 5 — The Procedure: The patient is placed in the dorsal lithotomy position. A speculum is inserted. For LLETZ/RF diathermy, intracervical local anaesthetic (1% lignocaine with 1:100,000 adrenaline) is administered at the 3, 6, 9, and 12 o'clock positions. The selected energy modality is applied under colposcopic or direct vision (total active treatment time: 5–20 minutes depending on technique). Ball diathermy or Monsel's solution is applied for haemostasis if needed. Total time in the procedure room: 20–40 minutes. • Step 6 — Recovery Room: 1–2 hours of observation. Vital signs, bleeding check. Mild cramping is managed with ibuprofen 400 mg or paracetamol 1 g orally. The vast majority of patients are discharged on the same day. IMMEDIATE POST-PROCEDURE (Days 1–7): • Step 7 — Discharge Instructions: Expected vaginal discharge (watery, brownish, or blood-tinged) for 1–4 weeks. Patient is given written instructions to avoid: tampons (use sanitary pads only), sexual intercourse, swimming, strenuous exercise, and intravaginal products for a minimum of 4 weeks. Analgesics prescribed for cramping. Antibiotics (e.g., doxycycline 100 mg BD for 7 days) prescribed if concurrent Chlamydia screen was positive. • Step 8 — First Follow-up (Day 3–5): In-person or teleconsultation review. Check for signs of secondary infection (offensive discharge, fever >38°C, worsening pain) or delayed haemorrhage. If LLETZ was performed, histology results are reviewed at this visit. INTERMEDIATE RECOVERY (Weeks 1–4): • Step 9 — Fit-to-Fly Assessment (Day 7–10): The gynaecologist performs a speculum examination to confirm adequate healing and absence of active bleeding. A fit-to-fly letter is issued. Patients are advised to remain well-hydrated on the flight, wear graduated compression stockings (DVT prophylaxis), and avoid heavy lifting in transit. • Step 10 — Resumption of Activity: Light work from Day 3–5; desk/office work by Week 1. Avoid sexual intercourse for 4 full weeks (minimum). Light exercise (walking) from Week 1; gym/swimming from Week 4–6. LONG-TERM FOLLOW-UP (Months 3–12): • Step 11 — Remote Follow-up (Month 3): Teleconsultation with the GAF Healthcare patient liaison. Symptom review: has discharge, PCB, or discomfort resolved? If yes, standard smear/HPV follow-up per national programme applies. • Step 12 — Repeat Colposcopy (Month 4–6): Recommended for LLETZ patients; HPV test of cure at 6 months (per NHSCSP/ASCCP protocol). If HPV-negative at 6 months, return to routine 5-yearly screening. If HPV-positive, colposcopy repeated at 12 months. • Step 13 — Discharge from Active Follow-up: Most patients are discharged from specialist follow-up at 6–12 months with confirmed symptom resolution and negative HPV test of cure.
Возможные риски
Cervical cautery is a low-risk, outpatient procedure, but patients must be fully informed of the following specific risks before consenting to treatment: COMMON AND EXPECTED EFFECTS (not complications): • Mild-to-moderate uterine cramping during and for 24–48 hours after the procedure (managed with NSAIDs) • Watery or blood-tinged vaginal discharge lasting 2–4 weeks (physiological healing response) • Slight spotting or light bleeding for up to 7 days post-procedure UNCOMMON BUT CLINICALLY IMPORTANT RISKS (1–5%): • Secondary infection/cervicitis: Ascending infection causing increased pain, offensive discharge, and fever. Risk minimised by pre-procedure STI screening and post-procedure hygiene adherence. Treated with targeted antibiotics. • Delayed haemorrhage (secondary PPH equivalent): Occurs at 7–14 days as the eschar separates; more common with LLETZ than ablative techniques. Most cases self-resolve or are managed with Monsel's solution application; rarely requires hospital readmission. • Incomplete treatment/recurrence: Up to 10–15% of large or deeply glandular ectropions may require a second treatment session. Ensure your treating clinician documents transformation zone type (type 1, 2, or 3) and advises on re-treatment probability before the procedure. RARE RISKS (<1%): • Cervical stenosis: Scar tissue formation at the endocervical os following LLETZ, particularly with deep or repeat excisions. Can cause dysmenorrhoea, haematometra, and subfertility. Risk is higher with excision depths >10 mm. Patients wishing to conceive should discuss conservative excision depths with their surgeon. • Cervical incompetence/preterm birth risk: Large LLETZ excisions (>10 mm depth or >10 mm length) have been associated with a modest increase in preterm birth risk (OR approximately 1.5–2.0 in some meta-analyses). This risk is primarily relevant to LLETZ, not to surface ablation techniques. Women planning future pregnancies should be counselled specifically on this point and, where possible, the minimum effective excision should be performed. • Asherman's-adjacent intrauterine adhesions: Extremely rare; not directly associated with cervical cautery but relevant if concurrent uterine procedures are performed. • Failure to diagnose underlying pathology: This is the primary safety risk. Ablative techniques (cryotherapy, cold coagulation, diathermy) destroy tissue without providing a specimen. If there is any colposcopic uncertainty, LLETZ must be used to obtain histology. At GAF Healthcare partner centres, ablation is never offered without a documented negative or low-grade biopsy result. IMPORTANT CAVEAT FOR TRAVELLING PATIENTS: Patients must plan their travel to ensure they are within reach of a medical facility during the first 14 days post-procedure, particularly around the Day 7–14 eschar-separation window when secondary bleeding risk is highest. GAF Healthcare provides emergency liaison contacts at all partner hospitals for this reason.
Почему GAF Healthcare
GAF Healthcare provides comprehensive end-to-end non-medical support for international patients undergoing cervical cautery in India or the UAE, ensuring that patients can focus entirely on their treatment and recovery. INDIA LOGISTICS: • e-Medical Visa: GAF Healthcare's visa assistance team guides patients through the Indian e-Medical Visa application (available for citizens of 150+ countries at indianvisaonline.gov.in). The e-Medical Visa allows up to 3 entries, is valid for 60 days, and is typically approved within 3–5 business days. Two attendant e-Medical Visas (for accompanying family members) are also facilitated at the same time. GAF Healthcare provides the official hospital invitation letter required as part of the application. • Airport Transfers: Private vehicle transfers are arranged from the arrival airport to the partner hospital and to accommodation. All vehicles are air-conditioned and driven by vetted chauffeurs; transfers are tracked by the GAF patient co-ordinator. • Dedicated Patient Co-ordinator: A named GAF Healthcare case manager is reachable via WhatsApp, phone, and email 7 days a week throughout the patient's stay. The co-ordinator attends key appointments, handles appointment scheduling, and liaises between the patient and the clinical team. • Language Support: Professional medical interpreters (Hindi, Tamil, Kannada, Malayalam, Bengali) are available at NABH/JCI partner hospitals in Delhi, Mumbai, Chennai, Bengaluru, and Hyderabad. International patients consulting in English require no translation at tier-1 centres where all specialist staff are English-proficient. • Attendant Accommodation: GAF Healthcare partners with serviced apartments and hospital guesthouses within 1–3 km of partner hospitals, providing clean, safe, Wi-Fi-enabled accommodation for the patient's companion at negotiated rates of $25–$80 per night depending on city and standard. • SIM Card & Connectivity: A local Indian SIM card with data is arranged pre-arrival for seamless communication. UAE (DUBAI / ABU DHABI) LOGISTICS: • Visa: Citizens of 100+ countries (including all EU, UK, US, Australian, and GCC nationals) receive a visa-free entry or visa-on-arrival for up to 30–90 days. For patients from countries requiring advance visas, GAF Healthcare facilitates the UAE tourist/medical visa application in collaboration with the receiving hospital. No special medical visa category is required in the UAE. • Airport Transfers: Private luxury transfers from Dubai International (DXB), Al Maktoum International (DWC), or Abu Dhabi International (AUH) to the hospital and hotel are arranged. Premium SUV or sedan options are available. • Dedicated Patient Co-ordinator: Same model as India — a named, bilingual (English and Arabic) case manager is available throughout the stay. • Language Support: JCI-accredited UAE hospitals (Cleveland Clinic Abu Dhabi, Mediclinic City Hospital, American Hospital Dubai, Saudi German Hospital) maintain formal medical interpretation services in Arabic, Urdu, Hindi, Russian, and English as standard. GAF Healthcare can additionally source interpreters in French, Tagalog, and other languages with 48-hour notice. • Attendant Accommodation: GAF Healthcare has preferred rate agreements with 3-star to 5-star hotels within close proximity to partner hospitals in Dubai Healthcare City, Al Reem Island (Abu Dhabi), and Jumeirah. Rates range from $80–$250 per night. • Health Insurance & Billing: GAF Healthcare assists patients in understanding whether their home-country insurance policy covers treatment in the UAE and provides itemised pro-forma invoices for insurance pre-authorisation where applicable. ALL DESTINATIONS — ADDITIONAL SERVICES: • Pre-travel telemedicine consultation with the treating gynaecologist • Digital medical records management and secure file transfer • Post-departure teleconsultation follow-up at 3 days, 1 week, and 1 month • Emergency medical liaison: 24/7 contact number for any post-procedure concerns during the stay • Fit-to-fly documentation and coordination of medical summary for the patient's home GP or gynaecologist
Частые вопросы о процедуре «Cervical Cautery (Cervical Erosion Treatment)»
What is the cost of Cervical Cautery (Cervical Erosion Treatment) in India versus the UAE?
How long do I need to stay in the country before I am fit to fly home after cervical cautery?
What is the success rate of Cervical Cautery (Cervical Erosion Treatment)?
Похожие страницы
Как GAF Healthcare помогает выбрать лучшую больницу для «cervical cautery (cervical erosion treatment)» в Дубай, ОАЭ
Найдите лучшие больницы для «cervical cautery (cervical erosion treatment)» в Дубай, ОАЭ
На этой странице представлено 3 больниц в Дубай, ОАЭ, чтобы вы могли сравнить аккредитацию и специализации в одном месте.
Поддержка, когда она нужна
Отправьте нам свои медицинские отчёты в WhatsApp или по email — наша медицинская команда изучит их и предложит больницу и план лечения.
Прозрачные, всё включено цены
Мы предоставляем единую детализированную смету, покрывающую расходы больницы и проживание — без скрытых платежей.
Организация визы, поездки и проживания
После выбора больницы мы помогаем оформить визовое приглашение, забронировать проживание рядом с больницей и организовать трансфер.
Хотите узнать примерную стоимость лечения? Используйте наш калькулятор стоимости для персональной оценки.
Частые вопросы о «Cervical Cautery (Cervical Erosion Treatment)» в Дубай, ОАЭ
Сколько больниц направления «Гинекология» представлено в Дубай, ОАЭ?
Как вы выбираете больницы для списка?
Сколько стоит лечение в Дубай, ОАЭ?
Следующий шаг
Отправьте нам свои медицинские отчёты — наша команда предложит больницу и план лечения для «Cervical Cautery (Cervical Erosion Treatment)» в Дубай, ОАЭ.
Свяжитесь с нами, если заметите неточность на этой странице.